Macquarie Group »

Soleno Therapeutics shares owned by Macquarie Group

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Macquarie Group from 13F filings

Historical chart of Macquarie Group investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Macquarie Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Macquarie Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.8M 26k 67.61
2024-03-31 $73 1.7k 0.04

More positions owned by Macquarie Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Ishares Tr Mortge Rel Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Visa Com Cl A (V)
Mastercard Incorporated Cl A (MA)
Howmet Aerospace (HWM)
Micron Technology (MU)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Macquarie Group

Top funds holding Soleno Therapeutics

FMR
Henderson Group
BlackRock
Vanguard Group
venBio Select Advisor
Wellington Management Company
Vivo Capital
State Street Corporation
Invesco
Caption Management
Adage Capital Partners GP
Commodore Capital
Braidwell
Millennium Management
Polar Capital Holdings

View all funds holding Soleno Therapeutics